- ByInvesting.com-
Investing.com -- After one of the worst relative years on record for the chemicals sector, signs are emerging that the prolonged...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 236.40 | 238.00 | 234.00 | -2.40 | -1.01% | 24.01K | ||
| 86.95 | 87.50 | 86.25 | -0.60 | -0.69% | 45.77K | ||
| 115.75 | 116.60 | 114.55 | -0.95 | -0.81% | 305.73K | ||
| 24.80 | 25.00 | 24.12 | -0.62 | -2.44% | 863.92K | ||
| 78.30 | 78.40 | 77.70 | -0.35 | -0.45% | 74.15K | ||
| 256.40 | 256.40 | 250.70 | -1.50 | -0.58% | 192.83K | ||
| 58.50 | 58.98 | 58.02 | -0.20 | -0.34% | 1.5M | ||
| 59.80 | 61.20 | 59.80 | -1.75 | -2.84% | 370.28K | ||
| 18.99 | 19.08 | 18.50 | -0.19 | -0.99% | 370.64K | ||
| 74.00 | 74.35 | 73.40 | -0.50 | -0.67% | 134.66K | ||
| 112.80 | 115.00 | 111.80 | -2.50 | -2.17% | 82.96K | ||
| 8,970.0 | 9,070.0 | 8,780.0 | -130.0 | -1.43% | 912 | ||
| 62.65 | 63.05 | 61.90 | -0.85 | -1.34% | 84.82K | ||
| 71.90 | 72.80 | 71.90 | -0.90 | -1.24% | 24.01K | ||
| 249.40 | 252.60 | 249.20 | -3.80 | -1.50% | 23.64K | ||
| 22.48 | 23.16 | 22.40 | -0.70 | -3.02% | 388.21K | ||
| 182.10 | 182.60 | 178.10 | +0.80 | +0.44% | 80.56K | ||
| 685.80 | 687.40 | 663.20 | +12.40 | +1.84% | 70.59K | ||
| 7.94 | 8.10 | 7.89 | -0.14 | -1.73% | 451.94K | ||
| 69.40 | 70.38 | 69.16 | -1.56 | -2.20% | 119.21K |
Investing.com -- After one of the worst relative years on record for the chemicals sector, signs are emerging that the prolonged...
Investing.com -- UBS outlined three Buy-rated European pharmaceutical and biotech companies positioned for growth in 2026, with...
Investing.com -- European consumer staples stocks remain under pressure from subdued demand and easing pricing momentum, but J.P....
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...
No Earning Reports have been scheduled